Next-generation Protein A ligand — higher capacity, caustic-stable, lower cost.
NGL-Impact® A is a next-generation Protein A ligand co-developed by Repligen and Navigo Proteins through wild-type Protein A shuffling, screening and multimerisation. The resulting capture resin delivers superior binding capacity, enhanced caustic stability and improved elution while lowering cost and optimising process economics for monoclonal antibody purification.
Immobilised on Purolite's Praesto® jetted-agarose bead technology, the ligand exhibits ultra-high binding capacity and excellent alkaline stability. These properties improve antibody capture for higher upstream titers and allow higher sodium hydroxide concentrations during sanitisation, extending resin lifespan and reducing consumable expense.
- Biopharma
- Pharmaceutical